Bristol Myers Squibb · 14 hours ago
Executive Director, Global Labeling
Bristol Myers Squibb is a company dedicated to transforming the lives of patients through innovative work. They are seeking an Executive Director, Global Labeling to lead a high-performing team responsible for developing and executing global regulatory labeling strategies, ensuring compliance and efficiency in labeling operations.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Builds and leads a high-performing global labeling team, fostering a culture of excellence, accountability, and innovation
Recruits, develops, and retains top talent, ensuring the team has the right mix of skills and experience
Establishes clear roles, responsibilities, and career development paths to support team growth and engagement
Translates strategy into operational goals, priority and plans Identifies necessary resources in order to ensure that Global Labeling is adequately staffed and trained to fulfill its function in providing consistent standards of support and in achieving superior execution of plans
Influences internal and external stakeholders, including health authorities, to shape labeling outcomes
Defines and establishes effective processes, SOPs, and work practices to drive consistency and efficiency, as appropriate
Develops strong working relationships with the key stakeholders within Global Regulatory Sciences, within Drug Development, Medical, Global Product Development & Supply and BMS enterprise
Acts as a credible, influential and respected spokesperson and Is externally focused and results driven; optimizes unit deliverables for speed to patient
Proactively manages Labeling Book of Work and monitors progress against submission timelines, prioritizes resources to meet Company objectives
Oversee continuous improvement of E2E Labeling Initiative to establish well-documented optimized sustainable E2E labeling process with clear ownership, simplified process steps and increased compliance
Identifies trends in labeling-related regulatory authority compliance enforcement, policies and procedures; incorporates into regulatory decisions and strategy
Strategic oversight of Labeling Management responsible for development, review and approval of artwork for US, EU and international packaging components and ensure launch readiness for BMS products
Champions digital innovation, including e-labeling and structured content management
Participates and drives Global Labeling Policy, partnering with Global Regulatory Policy, Identifies opportunities to influence regulatory policy and climate with respect to labeling content and electronic labeling
Keeps abreast of Regulatory changes, changes in authorities and requirements to enhance the effectiveness of the team and execution of regulatory deliverables
Accountable for the effective and efficient execution of the E2E Labeling process as well as ensure full compliance with all internal and external regulatory requirements
Ensures audit readiness and compliance with global regulatory standards and internal policies
Qualification
Required
PhD / Pharm D / MD or equivalent, with thorough understanding of scientific principles, regulatory and business issues with 15 years of Pharma / R&D experience with broad regulatory experience
Demonstrates strategic vision and the ability to set direction aligned with company objectives
Exhibits strong executive presence and influence across program teams and organizational initiatives
Authentically builds trusted relationships and collaborates across global, diverse, and multi-functional teams to drive business objectives
Serves as a strong judge of talent with the ability to make tough talent decisions
Possesses excellent communication and stakeholder engagement skills across functions and geographies
Has experience in upskilling teams, promoting digital transformation, and embedding agile practices
Assimilates and presents complex scientific and regulatory information concisely
Understands regulatory implications of product strategy related to labeling development, assessment, and management
Demonstrates strong problem-solving, decision-making, and analytical skills
Commits to professional and ethical business practices
Fosters a digital-first mindset and builds digital capabilities across teams
Benefits
Health Coverage Medical, pharmacy, dental, and vision care.
Wellbeing Support Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
US Exempt Employees flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
H1B Sponsorship
Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)
Funding
Current Stage
Public CompanyTotal Funding
$29.33BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.75B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Recent News
2026-02-03
Company data provided by crunchbase